Forecast & Rating4 analysts currently cover Supernus Pharma, of which 3 give a positive rating. The average price target is $61.75, about 30.1% upside from the current price of $47.45. Coverage is limited, so the data is for reference only. Data as of Aug 7, 2026; this does not constitute investment advice.
Aug 7, 2026Price forecast
$61.7530.14%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met49.8%
Stock price$47.45
Avg. target$61.3
High target$65
Low target$55
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.